Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Msystems|March 2, 2023
The Coming of Age of Nucleic Acid Vaccines during COVID-19Halie M Rando, Ronan Lordan, Likhitha Kolla, et al.Journal for Immunotherapy of Cancer|June 4, 2024
Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinomaRyan P O'Connell, Kevin Liaw, Nils Wellhausen, et al.Arxiv|May 13, 2022
Molecular and Serologic Diagnostic Technologies for SARS-CoV-2Halie M Rando, Christian Brueffer, Ronan Lordan, et al.Science Translational Medicine|August 31, 2023
Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapyNils Wellhausen, Ryan P O'Connell, Stefanie Lesch, et al.Cancer Cell|June 6, 2025
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapyAlexander Benton, Jiageng Liu, Mathilde A Poussin, et al.Biorxiv : the Preprint Server for Biology|September 5, 2025
An integrated enzymatic and computational pipeline for quantifying off-target base-editingAlexander G McFarland, Soon-Keat Ooi, Davin Tafuri, et al.Proceedings of the National Academy of Sciences of the United States of America|February 26, 2024
Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53αChristopher Roselle, Izumi Horikawa, Linhui Chen, et al.Cancer Immunology Research|June 13, 2024
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen ReceptorsJu-Fang Chang, Nils Wellhausen, Nils W Engel, et al.Proceedings of the National Academy of Sciences of the United States of America|May 5, 2025
Quadruple adenine base-edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease-engineered T cellsNils W Engel, Israel Steinfeld, Daniel Ryan, et al.Arxiv|March 10, 2021
Identification and Development of Therapeutics for COVID-19Halie M Rando, Nils Wellhausen, Soumita Ghosh, et al.Pageof 3